05/17/2018 Quarterly Report - REVISED 1Q 2018 F
Post# of 11802
(Total Views: 339)
Posted On: 05/21/2018 11:15:22 AM
05/17/2018
Quarterly Report - REVISED 1Q 2018 FINANCIALS_FOOTNOTES AND SCHEDULES
NOTE 8 – Stockholder’s equity
2018 Issuances
Preferred
During the quarter ended March 31, 2018, we issued 100,000 shares of preferred series “E” shares for
services valued at $6,000.
During the quarter ended March 31, 2018, holders of our preferred series “E” shares elected to convert
170,000 preferred series “E” shares into 2,380,000 shares of our $0.001 par value common stock.
NOTE 11 – Subsequent Events
On May 15, 2018 the company closed additional financing in the form of OID Notes and Warrants in the amount of $400,000
face value, with Alpha Capital Anstalt and Chase Financing, Inc., the company’s main financiers.
https://backend.otcmarkets.com/otcapi/company...75/content
Quarterly Report - REVISED 1Q 2018 FINANCIALS_FOOTNOTES AND SCHEDULES
NOTE 8 – Stockholder’s equity
2018 Issuances
Preferred
During the quarter ended March 31, 2018, we issued 100,000 shares of preferred series “E” shares for
services valued at $6,000.
During the quarter ended March 31, 2018, holders of our preferred series “E” shares elected to convert
170,000 preferred series “E” shares into 2,380,000 shares of our $0.001 par value common stock.
NOTE 11 – Subsequent Events
On May 15, 2018 the company closed additional financing in the form of OID Notes and Warrants in the amount of $400,000
face value, with Alpha Capital Anstalt and Chase Financing, Inc., the company’s main financiers.
https://backend.otcmarkets.com/otcapi/company...75/content
(3)
(0)Decision Diagnostics Corp (DECN) Stock Research Links
Scroll down for more posts ▼